According to a report by Pledge Times on August 6, Professor Tony Lawler, director of the Therapeutic Goods Administration (TGA) in Australia, emphasized during a meeting that the Therapeutic Goods Order 100 will ensure the quality and safety of therapeutic e-cigarette products. He acknowledged the challenges pharmacists face when evaluating unregistered products, and highlighted that regulatory reforms and enhanced border control measures help manage imported products. These products must be regulated as therapeutic goods, which is why they are not sold in retail environments.
He assured pharmaceutical professionals that the responsibility for ensuring the safety of e-cigarette products to the public does not solely rest on community pharmacists.
He also emphasized strict control over the concentration, flavor, and color of e-cigarettes, and pointed out that e-cigarettes are being withdrawn from retail environments to ensure they are managed by health professionals. He stressed that only e-cigarette products that meet TGA standards can be imported and sold in Australia.
According to reports, the Therapeutic Goods Administration (TGA) and the Queensland Department of Health recently conducted a two-day joint enforcement operation, seizing over 10,000 nicotine pouches and hundreds of illegal e-cigarette products. The confiscated e-cigarettes are suspected of violating the new commercial possession laws under the Therapeutic Goods and Other Legislation Amendment (E-cigarette Reform) Act, which came into effect on July 1st. These laws prohibit Australian retailers from providing any e-cigarette products, even with a prescription, and prohibit the possession of e-cigarettes in retail premises.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
